Lexicon Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025

Company Announcement - Lexicon Pharmaceuticals, Inc. will release its first quarter 2025 financial results on May 13, 2025, after market close [1] - A conference call and live webcast will be held on the same day at 5:00 p.m. ET to discuss the financial results and provide a business update [1] Conference Call Access - Participants can access the conference call live via the company's website [2] - Registration is required for participants who wish to ask questions, providing them with dial-in numbers and a unique pin [2] - An archived version of the webcast will be available on the Lexicon website [2] Company Overview - Lexicon is a biopharmaceutical company focused on pioneering medicines that transform patients' lives [3] - The Genome5000™ program has enabled Lexicon to study nearly 5,000 genes, identifying over 100 protein targets with significant therapeutic potential [3] - The company has advanced multiple medicines to market and has a pipeline of drug candidates in various stages of development for conditions such as heart failure, neuropathic pain, obesity, cardiology, and diabetes [3]